Haryana Health Minister Anil Vij Leads By Example, Becomes Volunteer For Trial Dose Of COVAXIN
The third phase trial of Bharat Biotech's COVAXIN began in the state and the 67-year old senior Bharatiya Janata Party leader was administered the trial dose at the Civil Hospital at Ambala Cantt, becoming the first volunteer in the state.
As the clinical trials of Covaxin progress across the country, Haryana Health Minister Anil Vij was on Friday administered a trial dose of the potential coronavirus vaccine.
The third phase trial of Bharat Biotech's Covaxin began in the state and the 67-year old senior Bharatiya Janata Party leader was administered the trial dose at the Civil Hospital at Ambala Cantt, becoming the first volunteer in the state.
BCCL
Vij is stated to be the first cabinet minister of any state government who has volunteered to take the trial dose of a potential vaccine against COVID-19.
On November 18, Vij had offered to become the "first volunteer" for Phase-III clinical trial of the vaccine
Civil Surgeon, Ambala, Dr. Kuldeep Singh told reporters that the COVAXIN dose was administrated to Vij successfully.
Many lauded him for his initiative.
Finally after a long time Political Leader is behaving like a ??????.#Covaxin #anilvij @anilvijminister https://t.co/amFhUirWu2
¡ª Aditya Goswami (@aditya_goswami_) November 20, 2020
Haryana Health Minister Anil Vij volunteers for trial dose of COVID-19 vaccine #Covaxin...
¡ª Kittu (@jhampakjhum) November 20, 2020
Entire public to him : pic.twitter.com/edO4pcUITZ
Respect for u #anilvij Sir..
¡ª Asif Iqubal (@asif_iqubal01) November 20, 2020
Sign of true leader..????#Covaxin pic.twitter.com/ODQCChgwaD
This what leader do.
¡ª Amir Yadav (@S9Yadav) November 20, 2020
Salute to health minister of Haryana Anil Vij ji. https://t.co/riHL2ECBIy
Earlier the minister underwent some tests at the hospital, where he was kept under observation for some time after being administered the vaccine.
Before reaching the civil hospital, Vij, while talking to media persons, said if all goes well, the vaccine against COVID-19 will be available to the people by the beginning of next year.
ANI
To a query, Vij, who has diabetes and had undergone a surgery, said he was not suffering from any such disease which will affect him adversely after taking the vaccine.
The MLA from Ambala Cantt, had on Wednesday said the third phase of trial of COVAXIN will begin in the state on November 20 and had offered to get vaccinated.
COVAXIN is being developed indigenously by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).
Last month, the vaccine maker said it had successfully completed interim analysis of Phase 1 and 2 trials and is initiating Phase 3 trials.
Bharat Biotech had on Monday said the Phase 3 trial of COVAXIN will involve 26,000 volunteers across 25 centres in India and is being conducted in partnership with the ICMR.
It is the largest clinical trial conducted for a COVID-19 vaccine in India.
This is India's first Phase 3 efficacy study for a COVID-19 vaccine, and the largest Phase 3 efficacy trial ever conducted.
Human trials of COVAXIN had begun at Rohtak's Post Graduate Institute of Medical Sciences in July, Vij had said earlier.
Bobins Abraham is the Assistant News Editor at Indiatimes. He has more than twelve years of experience in TV and digital journalism. An avid student of history and geopolitics, he is a conservationist and environmentalist at heart. He writes on environment, sustainability, human-animal conflict and more.
Read More
